Article
Reversal of advanced fibrosis after long-term ursodeoxycholic acid therapy in a patient with residual expression of MDR3.
Annals of hepatology - 1 Jan 2000
Frider Bernardo, Castillo Amalia, Gordo-Gilart Raquel, Bruno Andrés, Amante Marcelo, Alvarez Luis, Mathet Verónica
Abstract excerpt
INTRODUCTION: Progressive familial intrahepatic cholestasis type 3 (PFIC-3) is a severe liver disorder associated with inherited dysfunction of multidrug resistance protein 3 (MDR3/ABCB4), which functions as a phospholipid floppase, translocating phosphatidylcholine from the inner to the outer hemileaflet of the canalicular membrane of hepatocytes. MDR3 deficiency results in a disbalanced bile which may damage...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
